We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MSFT:NASDAQMicrosoft Corporation Analysis

Data as of 2026-08-25 - not real-time

$487.31

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Microsoft Corporation trades at $487.31, with its moving averages tangled rather than clearly stacked — a neutral trend structure. The last 30 days have gained 24.6%. Momentum indicators put RSI at 64.0 (approaching overbought) with MACD reading bearish. Recent trading has carved out support near $388.74 and resistance around $513.73.
The shares look fair, trading on 27.0 times earnings below a sector average of 34.6. The average analyst target implies 16.9% above today's level. Revenue is growing at 17.7% on a 40.3% profit margin. The 0.75% dividend yield looks covered by current payout levels.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 49.9%, a beta of 0.94 and a maximum drawdown of 34.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 5/10 conviction over the longer horizon.

Top Market Events

Eagle Capital Management, an investment management company, released its second quarter 2026 investor letter.Microsoft Corporation NASDAQ:MSFT has spent years watching Google and Amazon build their own AI chips while it stayed...On August 4, Reuters reported that Microsoft Corporation NASDAQ:MSFT , Meta Platforms, Inc.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Trading above the 200-day average of 431.18
  • MACD momentum is negative
  • 30-day price change of +24.6%

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 27.0 versus sector average of 34.6
  • Trading above the 200-day average of 431.18
  • Analyst targets imply +16.9% versus the current price

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 27.0 versus sector average of 34.6
  • Analyst targets imply +16.9% versus the current price
  • Profit margin of 40.3% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth17.70%
Profit Margin40.30%
P/E Ratio27.0
ROE34.04%
ROA14.09%
Debt/Equity29.12
P/B Ratio8.2
Op. Cash Flow$182.9B
Free Cash Flow$16.5B
Industry P/E34.6

Technical Analysis

TrendNeutral
RSI64.0
Support$388.74
Resistance$513.73
MA 20$478.00
MA 50$421.78
MA 200$431.18
MACDBearish
VolumeDecreasing
Fear & Greed Index93.13

Valuation

Fair Value$51.58
Target Price$569.45
Upside/Downside16.86%
GradeFair
TypeGrowth
Dividend Yield0.75%

Risk Assessment

Beta0.94
Volatility49.89%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.